Literature DB >> 11302483

Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis.

E Suehisa1, T Nomura, T Kawasaki, Y Kanakura.   

Abstract

One hundred and thirteen consecutive Japanese patients with deep venous thrombosis (DVT) were studied for the incidences of antithrombin III (AT-III), protein C (PC) and protein S (PS) deficiencies, and the results were compared with those of normal subjects. Ten of the 392 normal Japanese subjects were found with PS deficiency (n = 8, 2.02%) or PC deficiency (n = 2, 0.5%). PS deficiencies comprised type I (1/8, 12.5%), type 11 (4/8, 50%), and type III (3/8, 37.5%). All PC deficiencies were type I. Among patients with DVT, 32 (28.3%) were deficient in AT-III, PC and PS. These patients consisted of two AT-III deficiency (1.77%), nine PC deficiency (7.96%), 20 PS deficiency (17.7%), and one combined deficiency of PC and PS (0.88%). Both of the patients with AT-III deficiency were classified as type II, all those with PC deficiency as type I, and those with PS deficiency as type I in 25% (5/20), type II in 55% (11/20) and type III in 20% (4/20). The frequency of PC and PS deficiencies in patients with DVT were 15.6 and 7.38 times the control population frequency, respectively, and this difference was statistically significant (P < 0.05). These data suggest that the Japanese population has a high frequency of PC and PS deficiencies. We recommend that PS activity should be measured for screening of thrombosis since type II deficiency accounted for approximately 50% of PS deficiency cases in both patients and the normal group in the Japanese.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302483     DOI: 10.1097/00001721-200103000-00002

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  16 in total

Review 1.  Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation.

Authors:  Toshiyuki Miyata; Rina Kimura; Yoshihiro Kokubo; Toshiyuki Sakata
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

2.  Risk factors of acute pulmonary thromboembolism in Japanese patients hospitalized for medical illness: results of a multicenter registry in the Japanese society of pulmonary embolism research.

Authors:  Mashio Nakamura; Masahito Sakuma; Norikazu Yamada; Nobuhiro Tanabe; Norifumi Nakanishi; Yoshiyuki Miyahara; Takayuki Kuriyama; Takeyoshi Kunieda; Kunio Shirato; Tsuneaki Sugimoto; Takeshi Nakano
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

3.  Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group.

Authors:  Tienan Zhu; Qiulan Ding; Xia Bai; Xiaoyan Wang; Florentia Kaguelidou; Corinne Alberti; Xuqian Wei; Baolai Hua; Renchi Yang; Xuefeng Wang; Zhaoyue Wang; Changgeng Ruan; Nicole Schlegel; Yongqiang Zhao
Journal:  Haematologica       Date:  2011-04-12       Impact factor: 9.941

4.  The association of protein S Tokushima-K196E with a risk of deep vein thrombosis.

Authors:  Makoto Ikejiri; Hideo Wada; Yuko Sakamoto; Naohiko Ito; Junji Nishioka; Kaname Nakatani; Akihiro Tsuji; Norikazu Yamada; Mashio Nakamura; Masaaki Ito; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2010-09-02       Impact factor: 2.490

5.  Thrombophilia with an onset symptom of intracranial venous thrombosis: A case report and review of the literature.

Authors:  Li Cui; Lijun Zhu; Yuting Wang; Wuqiong Zhang; Shaokuan Fang
Journal:  Exp Ther Med       Date:  2017-04-06       Impact factor: 2.447

6.  Association between congenital thrombophilia and outcomes in pulmonary embolism patients.

Authors:  Tian-Yu Lian; Dan Lu; Xin-Xin Yan; Jiang-Shan Tan; Fu-Hua Peng; Yong-Jian Zhu; Yun-Peng Wei; Tao Wu; Kai Sun; Xin Jiang; Lu Hua; Zhi-Cheng Jing
Journal:  Blood Adv       Date:  2020-12-08

Review 7.  Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians.

Authors:  Tong Yin; Toshiyuki Miyata
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

8.  Risk factors of venous thromboembolism in thai patients.

Authors:  Pantep Angchaisuksiri; Vichai Atichartakarn; Katcharin Aryurachai; Napaporn Archararit; Buppa Rachakom; Kanlayanee Atamasirikul; Arjit Tiraganjana
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

9.  Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population.

Authors:  Hee-Jin Kim; Ja-Young Seo; Ki-O Lee; Sung-Hwan Bang; Seung-Tae Lee; Chang-Seok Ki; Jong-Won Kim; Chul Won Jung; Duk-Kyung Kim; Sun-Hee Kim
Journal:  Haematologica       Date:  2013-10-25       Impact factor: 9.941

10.  Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population.

Authors:  Liang Tang; Tao Guo; Rui Yang; Heng Mei; Huafang Wang; Xuan Lu; Jianming Yu; Qingyun Wang; Yu Hu
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.